{
    "clinical_study": {
        "@rank": "67181", 
        "arm_group": {
            "arm_group_label": "BMI control of MAHI Exo-II", 
            "arm_group_type": "Experimental", 
            "description": "MAHI EXO-II exoskeleton augmented with BMI system will be used to actively include the patient in the control loop, thereby making the therapy 'active' and engaging patients with various impairment severity in rehabilitation tasks. Patients will receive longitudinal training with the BMI-robotic interface for 3-4 sessions per week, over a period of 3 months."
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is:\n\n        1. To augment the MAHI Exo-II, a physical human exoskeleton, with a non-invasive brain\n           machine interface (BMI) to actively include patient in the control loop and thereby\n           making the therapy 'active'.\n\n        2. To determine appropriate robotic (kinematic data acquired through sensors on robotic\n           device ) and electrophysiological ( electroencephalography- EEG based) measures of arm\n           motor impairment and recovery after stroke.\n\n        3. To demonstrate that the BMI controlled MAHI Exo-II robotic arm training is feasible and\n           effective in improving arm motor functions in sub-acute and chronic stroke population."
        }, 
        "brief_title": "Brain Machine Interface Control of an Robotic Exoskeleton in Training Upper Extremity Functions in Stroke", 
        "completion_date": {
            "#text": "July 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Stroke", 
            "Hemiparesis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Paresis", 
                "Stroke", 
                "Cerebral Infarction"
            ]
        }, 
        "detailed_description": {
            "textblock": "This study aims to provide an adjunct to accelerate neurorehabilitation for stroke patients.\n      The MAHI EXO-II, a physical human-robot interface, will be combined with a non-invasive\n      brain-machine interface (BMI) to actively include the patient in the training of upper\n      extremity motor functions."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Diagnosis of unilateral cortical and subcortical stroke confirmed by brain CT or MRI\n             scan;\n\n          2. Subacute or chronic stroke; interval of at least 3month and interval of at least 6\n             months from stroke to time of enrollment, respectively;\n\n          3. No previous clinically defined stroke;\n\n          4. Age between 18-75 years;\n\n          5. Upper-extremity hemiparesis associated with stroke (manual muscle testing score of at\n             least 2, but no more than 4/5 in the elbow and wrist flexors);\n\n          6. No joint contracture or severe spasticity in the affected upper extremity: i.e.,\n             significant increase in muscle tone against passive ROM is no more than \u00bd of full\n             range for given joint e.g., elbow, wrist and forearm movements.\n\n          7. Sitting balance sufficient to participate with robotic activities;\n\n          8. No neglect that would preclude participation in the therapy protocol;\n\n          9. Upper limb proprioception present ( as tested by joint position sense of wrist);\n\n         10. No history of neurolytic procedure to the affected limb in the past four months and\n             no planned alteration in upper-extremity therapy or medication for muscle tone during\n             the course of the study;\n\n         11. No medical or surgical condition that will preclude participation in an occupational\n             therapy program, that includes among others, strengthening, motor control and\n             functional re-training of the upper limbs;\n\n         12. No contraindication to MRI;\n\n         13. No condition (e.g., severe arthritis, central pain) that would interfere with valid\n             administration of the motor function tests;\n\n         14. English-language comprehension and cognitive ability sufficient to give informed\n             consent and to cooperate with the intervention.-\n\n        Exclusion Criteria:\n\n          1. Orthopedic limitations of either upper extremity that would affect performance on the\n             study;\n\n          2. Untreated depression that may affect motivation to participate in the study;\n\n          3. Subjects who cannot provide self-transportation to the study location.\n\n        Inclusion and Exclusion Criteria for Health Subjects:\n\n        Inclusion criteria:\n\n          -  able to understand and sign the consent form\n\n          -  age 18-65\n\n        Exclusion criteria: - Previous history of or MRI findings consistent with brain tumors,\n        strokes, trauma or arterial venous malformations - Contraindication to MRI - Pregnancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01948739", 
            "org_study_id": "1R01NS081854", 
            "secondary_id": "1R01NS081854"
        }, 
        "intervention": {
            "arm_group_label": "BMI control of MAHI Exo-II", 
            "description": "In this longitudinal study, adult subjects with hemiparesis due to acute or chronic stroke will receive robotic-assisted training through an EEG-based BMI control of robotic exoskeleton to study the changes in upper extremity motor function, cortical plasticity (using the EEG and fMRI). The training will be provided 3x/week for 12 sessions over one-month period.", 
            "intervention_name": "MAHI EXO-II exoskeleton augmented with BMI system", 
            "intervention_type": "Device", 
            "other_name": [
                "Brain Machine Interface System", 
                "Rehabilitation robotics"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Brain machine interface", 
            "Rehabilitation robotics", 
            "Stroke", 
            "Hemiparesis"
        ], 
        "lastchanged_date": "April 14, 2014", 
        "link": [
            {
                "description": "Mechatronics and Haptic Interfaces (MAHI) Lab (Dr.O'Malley, Rice Uni)", 
                "url": "http://mahilab.rice.edu/"
            }, 
            {
                "description": "University of Houston Brain-Machine Interface System Team (Dr.Contreras-Vidal, UH)", 
                "url": "http://www.facebook.com/UHBMIST"
            }, 
            {
                "description": "The UTHealth Motor Recovery Lab at TIRR Memorial Hermann Hospital (Dr.Francisco, UTHealth)", 
                "url": "http://www.uth.tmc.edu/schools/med/phymed/research/?src=d1"
            }
        ], 
        "location": {
            "contact": {
                "email": "Nuray.Yozbatiran@uth.tmc.edu", 
                "last_name": "Nuray Yozbatiran, PhD", 
                "phone": "713-797-5282"
            }, 
            "facility": {
                "address": {
                    "city": "Houston", 
                    "country": "United States", 
                    "state": "Texas", 
                    "zip": "77030"
                }, 
                "name": "The Institute for Rehabilitation and Research (TIRR) at Memorial Hermann"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "NRI:BMI Control of a Therapeutic Exoskeleton", 
        "overall_contact": {
            "email": "omalley@rice.edu", 
            "last_name": "Marcia K. O'Malley, PhD", 
            "phone": "(713) 348-3545"
        }, 
        "overall_contact_backup": {
            "email": "Gerard.E.Francisco@uth.tmc.edu", 
            "last_name": "Gerard Francisco, MD", 
            "phone": "(713) 797-5246"
        }, 
        "overall_official": [
            {
                "affiliation": "William Marsh Rice University", 
                "last_name": "Marcia K. O'Malley, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of Houston", 
                "last_name": "Jose L. Contreras-Vidal, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "The University of Texas Health Science Center, Houston", 
                "last_name": "Gerard Francisco, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "The Methodist Hospital System", 
                "last_name": "Robert G. Grossman, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "FMA is a stroke-specific, performance based impairment index. It quantitatively measures impairment, based on Twitchell and Brunnstrom's concept of sequential stages of motor return in hemiplegic stroke patients. It uses an ordinal scale for scoring of 33 items for the upper limb component of the F-M scale; (0:can not perform; 1:can perform partially; 2:can perform fully). Total range is 0-66, 0 being poor and 66 normal.", 
                "measure": "Change from baseline in Fugl-Meyer Arm (FMA)Motor Score", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 4 weeks, 6 weeks, 12 weeks"
            }, 
            {
                "description": "EEG activity in the low-frequency delta band will be used to train the neural interface for MAHI-EXO II. This outcome measure will quantify the change in brain activity occurring as a result of the training session with the neural interface and the robot. It is hypothesized that delta band power will increase (i.e., activity will become \"stronger\") and more synchronized with movement of the MAHI-EXO II, with training.", 
                "measure": "Change in cortical dynamics measured by Electroencephalography (EEG)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 4 weeks, 6 weeks, 12 weeks"
            }, 
            {
                "description": "Trajectory error measure is defined as a normalized difference between the desired and the participant's trajectory from one point in the workspace to another. Lower values reflect better performance.", 
                "measure": "Change from baseline in robotic motor coordination measure: trajectory error (TE)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 4 weeks, 6 weeks, 12 weeks"
            }, 
            {
                "description": "Smoothness of movement (SM) measure is a correlation coefficient that express the correlation between the participant's speed profile and a speed profile of an ideal trajectory utilizing the minimum jerk principle. It takes values between 0-1, where 1 optimal movement smoothness and 0 indicating poorest movement quality i.e., jerky movement.", 
                "measure": "Change from baseline in robotic motor coordination measure: Smoothness of Movement (SM)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 4 weeks, 6 weeks, 12 weeks"
            }
        ], 
        "reference": [
            {
                "PMID": "21493978", 
                "citation": "Bradberry TJ, Gentili RJ, Contreras-Vidal JL. Fast attainment of computer cursor control with noninvasively acquired brain signals. J Neural Eng. 2011 Jun;8(3):036010. doi: 10.1088/1741-2560/8/3/036010. Epub 2011 Apr 15."
            }, 
            {
                "PMID": "22334347", 
                "citation": "Yozbatiran N, Berliner J, O'Malley MK, Pehlivan AU, Kadivar Z, Boake C, Francisco GE. Robotic training and clinical assessment of upper extremity movements after spinal cord injury: a single case report. J Rehabil Med. 2012 Feb;44(2):186-8. doi: 10.2340/16501977-0924."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01948739"
        }, 
        "responsible_party": {
            "investigator_affiliation": "William Marsh Rice University", 
            "investigator_full_name": "Marcia k. O'Malley", 
            "investigator_title": "Associate Professor of Mechanical Engineering", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "The JTHFT is a motor performance test and measures the time needed to perform 7 everyday activities (e.g., writing, feeding). Lower times represent better performance.", 
                "measure": "Change from baseline in Jebsen-Taylor Hand Function Test (JTHFT)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 4 weeks, 6 weeks, 12 weeks"
            }, 
            {
                "description": "The ARAT is used to assess subject's ability to manipulate-lift-release  objects horizontally and vertically, which differs in size, weight and shape. The test consists of 19 items divided into 4 sub-tests (grasp, grip, pinch, gross arm movement) and each item is rated on a 4-point scale. The possible total score ranges between 0-57. Higher scores indicate better performance.", 
                "measure": "Change from baseline in Action Research Arm Test (ARAT)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 4 weeks, 6 weeks, 12 weeks"
            }, 
            {
                "description": "Changes in brain networks, both structural and functional activation patterns associated with movement before and after training with the neural interface and robot will be assessed in this outcome measure.", 
                "measure": "Change in brain volume of activation and signal intensity using structural and functional magnetic resonance imaging", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 4 weeks"
            }, 
            {
                "description": "Pain and Fatigue will be measured on a visual analogue scale.  After each training session as well as at baseline, post-treatment and on follow up assessment, participants will be asked to rate their current pain  and fatigue on a scale ranging from 0 = none to 100 = worst possible.", 
                "measure": "Change from baseline in pain and fatigue", 
                "safety_issue": "Yes", 
                "time_frame": "Baseline, 4 weeks, 6 weeks, 12 weeks"
            }, 
            {
                "description": "A grip dynamometer or pinch gauge will be used to measure maximum gross grasp force and pinch force, respectively.", 
                "measure": "Change from baseline in grip and pinch strength", 
                "safety_issue": "No", 
                "time_frame": "Baseline,  4 weeks, 6 weeks, 12 weeks"
            }
        ], 
        "source": "The University of Texas Health Science Center, Houston", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "University of Houston", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "The Methodist Hospital System", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "National Institute of Neurological Disorders and Stroke (NINDS)", 
                    "agency_class": "NIH"
                }, 
                {
                    "agency": "TIRR Memorial Hermann", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "The University of Texas Health Science Center, Houston", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}